Hansa Biopharma AB at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Hello, everyone. I'm Christine Hofmeister, a member of the European investment banking team at Morgan Stanley. And it's my great pleasure today to welcome Søren Tulstrup, the CEO of Hansa Biopharma, to our fireside chat today.
Before we kick off, I just need to read a quick disclaimer so please bear with me. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you're a member of the press, please disconnect and reach out separately.
For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
With that, Søren, welcome to the session. It would be great if you could give us a quick introduction to Hansa and the story as it stands now. So I'm happy to hand over to you.
¸ - ()
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |